摘要
目的回顾性分析我院SICU于2002年1月～2007年12月期间接受过高容量血液滤过(HVHF)治疗的感染性休克患者在ICU的生存状况,评价早期HVHF对感染性休克的治疗作用。方法收集并整理患者的临床资料,包括患者在被诊断为感染性休克当天的APACHE-Ⅱ评分、SOFA评分、血清Cr水平以及住SICU期间的病死率。在被诊断为感染性休克的48小时内开始HVHF者为早期HVHF组,48小时后开始HVHF者为晚期HVHF组。比较两组在诊断为感染性休克当天的APACHE-Ⅱ评分、SOFA评分、血清Cr水平以及住SICU期间的病死率。结果68例感染性休克患者接受了HVHF治疗,早期HVHF组和晚期HVHF组的ICU病死率分别为40.0%(14/35)和63.6%(21/33)。在被诊断为感染性休克的当天,两组之间的APACHE-Ⅱ评分、SOFA评分和血Cr水平无明显差别(均P>0.05),早期HVHF组的ICU病死率显著低于晚期HVHF组(P<0.05)。结论早期HVHF降低了感染性休克患者的ICU病死率。
Objective To analyze retrospectively the ICU mortality of the patients with septic shock treated by high-volume hemofiltration(HVHF) in SICU of our hospital from Jan,2002 to Dec,2007 and evaluate the therapeutical roles of early HVHF on septic shock.Methods Data of patients was collected which included APACHE-Ⅱ score,SOFA score,serum creatinine on the 1st day of septic shock and mortality during SICU.The patients were devided into early-HVHF group and late-HVHF group according to the timing of HVHF,which th...
出处
《中国病案》
2009年第2期41-43,共3页
Chinese Medical Record
关键词
血液滤过
感染
休克
预后
Hemofiltration
Sepsis
Shock
Prognosis
